{
    "clinical_study": {
        "@rank": "114343", 
        "arm_group": [
            {
                "arm_group_label": "obese and overweight", 
                "description": "Group1 (n=30): overweight and obese (BMI \u226525 and/ or WHtR\u22650.5)"
            }, 
            {
                "arm_group_label": "average body weight", 
                "description": "Group2 (n=30): normal weight (BMI \u2265 18 to < 25 and/or WHtR \u22650.4 to <0.5)"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Control Group (n= 20): healthy subjects, matched for age and gender, were included in this study. All included controls had average weight (BMI \u2265 18 to < 25 and/ or WHtR \u22650.4 to <0.5)"
            }
        ], 
        "brief_summary": {
            "textblock": "evaluate the impact of different anthropometric measures on clinical and endoscopic severity\n      of GERD and its relation to serum leptin."
        }, 
        "brief_title": "Anthropometric Measures and Severity of Gastroesophageal Reflux Disease", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Gastroesophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gastro esophageal reflux symptoms (e.g. heart burn, regurgitation, water brash or\n             atypical symptoms such as hoarseness of voice, asthma and cough)\n\n          -  complete upper gastrointestinal endoscopy.\n\n        Exclusion Criteria:\n\n          -  Receiving medication for reflux disease (including proton pump inhibitor, histamine\n             type 2 receptors blocker, prokinetic agents) in the previous month.\n\n          -  Pregnant woman.\n\n          -  History of upper abdominal surgery.\n\n          -  Severe co-morbidity as cirrhosis, end-stage renal disease and heart failure."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "This prospective, case-controlled study included 60 Egyptian patients who attended Ain\n        Shams University Hospitals and Theodor Bilharz Research Institute; Cairo, Egypt"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954667", 
            "org_study_id": "Anthropometric Measures &GERD"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin", 
        "lastchanged_date": "September 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Tropical medicine department"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "3", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.", 
            "measure": "Impact of anthropometric measures on GERD", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954667"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Iman Fawzy Montasser", 
            "investigator_title": "Lecturer of tropical medicine , Ain Shams university", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ain Shams University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "6 Weeks", 
        "verification_date": "September 2013"
    }
}